| Literature DB >> 28911560 |
Pao-Huei Chen1, Yih-Ming Weng1, Zer-Ran Yu2, Malcolm Koo3, Be-Jen Wang1.
Abstract
Extraction temperature can potentially affect the chemical compositions and bioactivities of the extracts obtained. The objective of this study was to investigate the effect of extraction temperature on the distribution of bioactive compounds and the bioactivities of Pleurotus citrinopileatus. The antioxidant activities (2,2-diphenyl-1-picrylhydrazyl and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)+ scavenging capabilities) and the inhibitory capabilities on pancreatic α-amylase, intestinal α-glucosidase, and hypertension-linked angiotensin-converting enzyme of hot water P. citrinopileatus extract and cold water P. citrinopileatus extract were determined. The results showed that the antioxidant capabilities and inhibitory effects on α-amylase, α-glucosidase, and angiotensin-converting enzyme of cold water P. citrinopileatus extract were significantly higher than those of hot water P. citrinopileatus extract. The cold water P. citrinopileatus extracted was further precipitated with 100% ammonium sulfate to obtain a polysaccharide fraction or with 75% ethanol to obtain a protein fraction. The inhibitory activities of the protein fraction of the cold water P. citrinopileatus extract on α-amylase, α-glucosidase, and angiotensin-converting enzyme were significantly higher than those of the polysaccharide fraction. In conclusion, the protein fraction of the cold water P. citrinopileatus extract could be responsible for its bioactivities.Entities:
Keywords: Pleurotus citrinopileatus; angiotensin-converting enzyme; α-amylases; α-glucosidases
Mesh:
Substances:
Year: 2016 PMID: 28911560 PMCID: PMC9336654 DOI: 10.1016/j.jfda.2016.02.005
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Yield and component contents of extracts and precipitates of cold and hot water extracts from Pleurotus citrinopileatus.
| Sample | Yield (%) | Protein content (μg/mg) | Polysaccharide content (μg/mg) | Total phenolics content (μg GAE/mg) |
|---|---|---|---|---|
| Cold water extracts | ||||
| PCC-24H | 1.89 | 75.4 ± 1.5 | 238.6 ± 1.9 | 27.5 ± 0.3 |
| Hot water extracts | ||||
| PCH-1H | 1.12 | 42.3 ± 1.1 | 176.1 ± 1.3 | 14.2 ± 0.3 |
| PCH-2H | 1.19 | 49.3 ± 0.7 | 179.2 ± 1.0 | 16.4 ± 0.5 |
| 100% Ammonium sulfate precipitates | ||||
| PCC-Pr | 0.13 | 271.7 ± 1.7 | 142.8 ± 1.7 | 25.1 ± 0.3 |
| 75% Ethanol precipitates | ||||
| PCC-Ps | 0.21 | 38.4 ± 0.7 | 539.8 ± 2.3 | 5.0 ± 0.1 |
GAE = gallic acid equivalent.
Figure 1(A) 2,2-Diphenyl-1-picrylhydrazyl (DPPH) scavenging activity; (B) Trolox equivalent antioxidant capacity (TEAC) of PCC-24H, PCH-1H, and PCH-2H. Data with different letters were significantly different among extractions at same concentrations using Duncan’s new multiple range test (p < 0.05). BHA = 2(3)-t-butyl-4-hydroxyanisole.
The IC50 values for bioactivities, including 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging capability, inhibitory activities on α-amylase, α-glucosidase, and angiotensin-converting enzyme of extracts and fractions from Pleurotus citrinopileatus.
| Sample | IC50 | |||
|---|---|---|---|---|
|
| ||||
| DPPH | α-Amylase | α-Glucosidase | ACE | |
| Positive control | ||||
| BHA | 3.2 × 10−2 | ND | ND | ND |
| Trolox | 4.0 × 10−2 | ND | ND | ND |
| Acarbose | ND | 0.5 | 1.7 | ND |
| Lisinopril | ND | ND | ND | 8.4 × 10−6 |
| Cold water extracts | ||||
| PCC-24H | 0.6 | 7.1 | 7.6 | 4.6 |
| Hot water extracts | ||||
| PCH-1H | 2.1 | NI | 27.1 | 9.6 |
| PCH-2H | 1.8 | 61.7 | 27.7 | 7.2 |
| 100% Ammonium sulfate precipitates | ||||
| PCC-Pr | 1.3 | 2.5 | 0.8 | 2.0 |
| 75% Ethanol precipitates | ||||
| PCC-Ps | 6.4 | 4.4 | 33.6 | 8.8 |
ACE = angiotensin-converting enzyme; BHA = gallic acid; ND = not determined; NI = no inhibition.
IC50 value is defined as the inhibitor concentration to inhibit 50% of activity.
No inhibition, less than 10% inhibition at the concentration of 10 mg/mL.
Figure 2(A) α-Amylase inhibitory activity; (B) α-glucosidase inhibitory activity of PCC-24H, PCH-1H, and PCH-2H. Data with different letters were significantly different among extractions at same concentrations using Duncan’s new multiple range test (p < 0.05).
Figure 3Angiotensin-converting enzyme (ACE) inhibitory of PCC-24H, PCH-1H and PCH-2H. Data are mean of triplicate determinations.
Figure 4(A) 2,2-Diphenyl-1-picrylhydrazyl (DPPH) scavenging activity; (B) Trolox equivalent antioxidant capacity (TEAC) of PCC-Pr and PCC-Ps. Data with different letters were significantly different between PCC-Pr and PCC-Ps at same concentrations by Student t test (p < 0.05). BHA = 2(3)-t-butyl-4-hydroxyanisole.
Figure 5(A) α-Amylase and (B) α-glucosidase inhibitory activity of PCC-Pr and PCC-Ps. Data with different letters were significantly different among fractions and control at same concentrations by Student t test (p < 0.05).
Figure 6Angiotensin-converting enzyme (ACE) inhibitory activity of PCC-Pr and PCC-Ps. Lisinopril was the positive control. Data are mean of triplicate determinations.